The court-appointed receiver for Uncle Nearest Premium Whiskey has warned that returning control to founders Fawn and Keith Weaver could trigger immediate foreclosure by lender Farm Credit, despite earlier optimism about the brand's recovery prospects.
The medtech giant surpassed financial expectations, driven by robust performance in its core imaging and pharmaceutical diagnostics segments, while outlining a strategic shift towards becoming a comprehensive healthcare solutions provider.
A historic wave of retiring Baby Boomer business owners is set to transfer an estimated $10 trillion in assets, but a severe shortage of prepared buyers and widespread lack of planning risks shuttering businesses, eroding jobs, and destabilizing local economies across the nation.
Spain's BBVA has joined the Qivalis consortium, a coalition of twelve major European banks building a euro-denominated stablecoin. The move signals a coordinated push by traditional finance to reclaim ground in the digital currency arena, currently dominated by U.S. issuers, under the new regulatory framework of MiCA.
Driven by a surge in its Specialty Medicines portfolio, GSK reports strong 2025 sales and profit growth, maintains its 2026 outlook, and signals confidence with a raised dividend.
As major indices surge, a cash-flow analysis identifies Kimberly-Clark, Seacoast Banking, and National Bank Holdings as potentially undervalued, with estimated discounts of up to 44%.
Amid market volatility, one investor outlines a strategic pivot towards Brookfield Renewable, Hormel Foods, and Clorox, betting on their resilient dividends and growth potential.
A poignant national touring exhibition, born from a mother's grief for her son Oscar Grant, uses birthday remembrances to humanize victims of police brutality and examine the enduring impact on communities.
Senator Tim Scott pushes back against a Justice Department investigation into Fed Chair Jerome Powell, calling it a political maneuver that is now jeopardizing the confirmation of President Trump's nominee to succeed Powell.
For retirees, neglecting to rebalance an investment portfolio is no longer a minor oversight—it's a critical risk that can amplify losses, deplete reserves, and permanently alter a retirement's trajectory. Behavioral biases and market momentum often conspire to create a dangerous imbalance between stocks and bonds, leaving savers exposed just when protection matters most.
The Texas-based independent theater chain has abruptly closed its entire Los Angeles footprint, the latest blow to an industry still grappling with post-pandemic recovery and shifting audience habits.
In a congressional hearing, Treasury Secretary Scott Bessent argued that the Federal Reserve's independence is contingent on public trust, a trust he claims was damaged by the central bank's handling of inflation. He also defended the right of presidents and lawmakers to comment on monetary policy.
Despite its nearly 8% yield, pipeline giant MPLX combines a fortress balance sheet with a multi-year growth backlog, offering investors a rare blend of high income and stability.
Coinbase Global's shares have tumbled alongside cryptocurrency prices, yet strong fundamentals and growing non-trading revenue streams are fueling a fierce debate among investors about whether the selloff has gone too far.
Wix.com stock faced significant pressure last month, with investors grappling with the long-term implications of artificial intelligence on its core website-building business model, despite the company's recent strategic acquisition.
Darden Restaurants announces the complete closure of the Bahama Breeze chain, with half its sites set for conversion to new concepts and the other half to close permanently by 2026.
As a historic wave of Baby Boomers approaches retirement, locking in a date demands more than financial readiness. Experts warn that overlooking healthcare gaps, market volatility, and the psychological shift from work can derail even the best-laid plans.
The investment manager has agreed to purchase a seven-project solar portfolio across England and Scotland, significantly boosting its renewable energy assets and deepening an existing partnership with the Greek energy group.
The pharmaceutical giant AbbVie projects profits exceeding analyst expectations for 2026, buoyed by the stellar performance of its newer immunology drugs Skyrizi and Rinvoq, which are successfully offsetting the decline of its former top-seller Humira.
Human Rights Watch's latest annual assessment warns of a deepening crisis for international human rights norms, citing concerted pressure from major powers and a rising tide of authoritarian governance affecting billions worldwide.
